Post-Treatment Assessment and Creating Imaging-Based Short- and Intermediate-Term Patient Outcomes

1 Views
Published
Faina Shtern, MD, President and CEO, AdMeTech Foundation, Boston, Massachusetts, introduces an international working group formed by the AdMeTech Foundation to advance research and clinical strategies for focal treatment of prostate cancer. The group addresses the promising potential of minimally invasive therapies, such as partial ablation, for reducing complications and improving quality of life compared to whole gland treatments. In this 10-minute presentation, Shtern highlights the critical intersection of precision imaging, patient care, and public health, emphasizing collaboration and innovation in advancing prostate cancer treatment.
Category
Urology
Be the first to comment